Business

Pyxis Oncology to Participate in September Investor and Industry Conferences

BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer and Chief Medical Officer, will participate in the following upcoming conferences. Investor Conferences 2025 Cantor Global Healthcare Conference, New York, NY, Wednesday, September 3, 2:45 p.m. ET – Fireside chat and investor one-

articlePyxis Oncology, Inc.August 21, 20252/company/pyxis-oncology-inc/news/pyxis-oncology-participate-september-investor-113000278
Pyxis Oncology to Participate in September Investor and Industry Conferences

About this update from Pyxis Oncology, Inc.

[{"type":"image","alt":"Pyxis Oncology","displaySize":"","headline":null,"caption":"Pyxis Oncology","className":"","disableSlideshowImg":false,"size":{"original":{"width":203,"height":105,"url":"https://media.zenfs.com/en/globenewswire.com/c663fbbdcef74ec76700a29d86aa098c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/IX0t534d6HFsYbdc2gj8WA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTE4NjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c663fbbdcef74ec76700a29d86aa098c","width":203,"height":105}},"lazy":false},{"type":"text","content":"BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer and Chief Medical Officer, will participate in the following upcoming conferences.","length":352,"tagName":"p"},{"type":"text","content":"Investor Conferences","length":20,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"2025 Cantor Global Healthcare Conference, New York, NY, Wednesday, September 3, 2:45 p.m. ET – Fireside chat and investor one-on-one meetings.","length":142,"tagName":"p"}]},{"val":[{"type":"text","content":"H.C. Wainwright 27th Annual Global Investment Conference, New York, NY, Monday, September 8, 10:30 a.m. ET – Fireside chat and investor one-on-one meetings.","length":156,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":298,"olType":false},{"type":"text","content":"Industry Conference","length":19,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"2nd Annual ADC and Novel Conjugates Partnering and Investment Summit, Boston, MA, Tuesday, September 9, 3:20 p.m. ET – Company presentation (not webcast).","length":154,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":154,"olType":false},{"type":"text","content":"Live webcasts and replays of the Cantor and H.C. Wainwright fireside chats will be available on the Events & Presentations page in the Investor Relations section of Pyxis Oncology’s website, ir.pyxisoncology.com.","length":216,"tagName":"p"},{"type":"text","content":"About Pyxis Oncology, Inc.Pyxis Oncology, Inc. is a clinical stage company focused on defeating difficult-to-treat cancers. The Company is efficiently building therapeutics that hold the potent...

More updates from Pyxis Oncology, Inc.

Investor ConferencesCantor Global Healthcare ConferenceChief Medical OfficerChief Executive OfficerFireside chatclinical stage companyOncology